ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer

May 5, 1995

“Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate

November 7, 1975

Three Studies Test Oncotype DX In Breast and Colon Cancers

October 26, 2012

Center Directors Urge NCI To Expand CTEP’s Treatment Referral Cntr.

March 12, 1993

In Brief: White House Finally Okays Marks To Panel; NCAB Seeks More Data In RFP Announcements

July 2, 1976

NCI Intramural Programs: Clinical Trials Support System Need Attention, report Advises DCS

December 19, 1997